Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Addendum, adjournment, aged, AI, antidilution, antitakeover, arbitration, attrition, batch, bear, Big, break, broken, bundled, buyer, cast, CEO, CFO, Chair, CISO, cloud, comment, Connecticut, contextualization, cushion, DCF, deep, deposited, disaster, disconfirming, discretionary, divergent, dossier, escalate, expressly, fake, FCPA, fraction, fundraising, gather, Gaza, GC, gigabase, Guideline, Hannah, HemeOne, herewith, infer, inside, intelligence, irrespective, Israel, judgement, Kama, language, lattice, LCD, legend, lymphoma, Mamuszka, mandatorily, medium, monumental, morale, multiplied, numerator, overseeing, pari, passu, perspective, phase, pill, PLA, poison, prioritize, rank, ratio, redemption, refinancing, remeasured, resell, residual, retaliatory, saving, sterling, strength, stricter, subordinated, takeover, therapy, Tradename, Twomey, unlisted, unsecured, unused, VWAP
Removed:
AAN, AAP, accruing, ACMG, annum, bad, BNGOW, borrowed, Borrower, circumvent, clarify, complementing, constituted, courier, deadline, disrupted, DoA, dosage, doubtful, EMEIA, encephalopathy, EpiPanelDx, exert, febrile, feel, finalize, forgiven, grown, heightening, ill, imager, infantile, informally, interrupt, Italy, iv, journal, Ladenburg, leasing, loan, LP, LSA, mandated, MCO, movement, occupy, oncology, outlining, pandemic, Paycheck, personalized, personally, PGx, PPP, preliminary, prepayment, presence, prevented, prospectively, prostate, removing, repeal, retrospective, revised, revision, Revolver, revolving, SBA, shelf, skip, Sweden, Thalmann, treated, Trump, underwriting, underwritten, unsolicited, vi, visit, West
Filing tables
Filing exhibits
Related press release
Associated BNGO transcripts
BNGO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (File Nos. 333-237070, 333-239360, 333-245762, 333-251956 and 333-252216) and Form S-8 (Nos. 333-227073, 333-230589, 333-237069, 333-245764, 333-248468, 333-254654, 333-260762 and 333-263176) of Bionano Genomics, Inc. (the “Company”) of our report dated March 5, 2024, relating to the consolidated financial statements which appear in this Annual Report on Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, P.C.
San Diego, California
March 5, 2024